14 Days
Source:
صحة
Revolution in Slimming Drugs Raises Concerns
The article discusses the revolution in medications for the treatment of obesity and fatty liver disease related to metabolism. It focuses on the development of smart drugs capable of regulating biological pathways within the body to effectively and safely treat obesity and its associated diseases. It explains that these new treatments rely on approved medications such as GLP-1 and GIP receptor agonists, including drugs like semaglutide and tirzepatide, which have achieved remarkable results in weight loss and reduction of liver fibrosis, while avoiding the risks associated with traditional surgeries. The article also highlights the challenges related to the increased risk of muscle mass loss, the importance of precise use of these therapies under medical supervision, and the necessity of avoiding unscientific or counterfeit prescriptions from social media platforms, which could lead to serious health complications. In conclusion, it emphasizes the importance of adhering to evidence-based medicine to achieve sustainable outcomes and not relying on quick or unreliable solutions.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)